Dietary fat: From foe to friend?

Science

Volumn 362, Issue 6416, 2018, Pages 764-770

  Ludwig, David S ^a,b   Willett, Walter C ^b,c   Volek, Jeff S ^d   Neuhouser, Marian L ^e  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CHANNING LABORATORY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

CANCER; CARBOHYDRATE; CARDIOVASCULAR DISEASE; DIABETES; DIET; FAT; METABOLISM; NUTRITION; OBESITY;

BODY WEIGHT MANAGEMENT; CARBOHYDRATE DIET; CARBOHYDRATE INTAKE; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CONSENSUS; DIABETES MELLITUS; DIETITIAN ATTITUDE; DISORDERS OF CARBOHYDRATE METABOLISM; FAT INTAKE; GLUCOSE INTOLERANCE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL; HUMAN; INSULIN RESISTANCE; KETOGENIC DIET; LONG TERM CARE; LOW CARBOHYDRATE DIET; LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL; MACRONUTRIENT; MALIGNANT NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL VALUE; OBESITY; PANCREAS ISLET BETA CELL; PATIENT COMPLIANCE; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; LOW FAT DIET;

CHRONIC DISEASE; DIET, FAT-RESTRICTED; DIETARY CARBOHYDRATES; DIETARY FATS; HUMANS;

EID: 85056581871     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aau2096     Document Type: Review

References (102)

1. U. S. Senate Select Committee on Nutrition and Human Needs, Dietary Goals for the United States, Second Edition (U.S. Government Printing Office, 1977).
2. D. Mozaffarian, D. S. Ludwig, JAMA 304, 681–682 (2010).
3. J. M. McGinnis, M. Nestle, Am. J. Clin. Nutr. 49, 23–28 (1989).
4. Public Health Service, U.S. Department of Health and Human Services, Healthy People 2000: National Health Promotion and Disease Prevention Objective (1991).
5. J. O. Hill, A. M. Prentice, Am. J. Clin. Nutr. 62, 264S–273S (1995).
6. G. L. Austin, L. G. Ogden, J. O. Hill, Am. J. Clin. Nutr. 93, 836–843 (2011).
7. D. S. Ludwig, JAMA 315, 2269–2270 (2016).
8. D. C. Willcox, B. J. Willcox, H. Todoriki, M. Suzuki, J. Am. Coll. Nutr. 28 (suppl.), 500S–516S (2009).
9. N. B. Bueno, I. S. de Melo, S. L. de Oliveira, T. da Rocha Ataide, Br. J. Nutr. 110, 1178–1187 (2013).
10. D. K. Tobias et al., Lancet Diabetes Endocrinol. 3, 968–979 (2015).
11. S. J. Hallberg et al., Diabetes Ther. 9, 583–612 (2018).
12. B. S. Lennerz et al., Pediatrics 141, e20173349 (2018).
13. F. Diraison et al., J. Lipid Res. 44, 846–853 (2003).
14. L. C. Hudgins et al., J. Nutr. Biochem. 19, 237–245 (2008).
15. E. J. Parks, R. M. Krauss, M. P. Christiansen, R. A. Neese, M. K. Hellerstein, J. Clin. Invest. 104, 1087–1096 (1999).
16. J. M. Schwarz, R. A. Neese, S. Turner, D. Dare, M. K. Hellerstein, J. Clin. Invest. 96, 2735–2743 (1995).
17. A. Astrup, A. Raben, Eur. J. Clin. Nutr. 46, 611–620 (1992).
18. J. E. Blundell, J. I. MacDiarmid, J. Am. Diet. Assoc. 97 (suppl.), S63–S69 (1997).
19. S. S. Runchey et al., Metabolism 62, 188–195 (2013).
20. S. Hu et al., Cell Metab. 28, 415–431.e4 (2018).
21. M. Valdearcos, A. W. Xu, S. K. Koliwad, Annu. Rev. Physiol. 77, 131–160 (2015).
22. S. K. Doerner et al., Mol. Cancer Res. 14, 953–965 (2016).
23. R. G. Snodgrass, S. Huang, I. W. Choi, J. C. Rutledge, D. H. Hwang, J. Immunol. 191, 4337–4347 (2013).
24. J. V. Heymach et al., Cancer Prev. Res. 4, 1590–1598 (2011).
25. E. M. Sullivan et al., Adv. Nutr. 9, 247–262 (2018).
26. A. Perfilyev et al., Am. J. Clin. Nutr. 105, 991–1000 (2017).
27. J. A. Martínez, F. I. Milagro, K. J. Claycombe, K. L. Schalinske, Adv. Nutr. 5, 71–81 (2014).
28. B. Paul et al., Clin. Epigenetics 7, 112 (2015).
29. S. J. O’Keefe, Nat. Rev. Gastroenterol. Hepatol. 13, 691–706 (2016).
30. S. Ocvirk, S. J. O’Keefe, Curr. Nutr. Rep. 6, 315–322 (2017).
31. J. Ou et al., Am. J. Clin. Nutr. 98, 111–120 (2013).
32. R. L. Prentice et al., JAMA 295, 629–642 (2006).
33. C. L. Rock et al., Metabolism 65, 1605–1613 (2016).
34. N. F. Boyd et al., J. Natl. Cancer Inst. 89, 488–496 (1997).
35. C. L. Carty et al., Am. J. Clin. Nutr. 93, 516–524 (2011).
36. A. Astrup, G. K. Grunwald, E. L. Melanson, W. H. M. Saris, J. O. Hill, Int. J. Obes. 24, 1545–1552 (2000).
37. Diabetes Prevention Program Research Group, N. Engl. J. Med. 346, 393–403 (2002).
38. S. V. Thompson, B. A. Hannon, R. An, H. D. Holscher, Am. J. Clin. Nutr. 106, 1514–1528 (2017).
39. B. V. Howard et al., JAMA 295, 655–666 (2006).
40. R. L. Prentice et al., Am. J. Clin. Nutr. 106, 35–43 (2017).
41. A. Whitehead, E. J. Beck, S. Tosh, T. M. Wolever, Am. J. Clin. Nutr. 100, 1413–1421 (2014).
42. A. J. Nordmann et al., Arch. Intern. Med. 166, 285–293 (2006).
43. L. J. Martin et al., Cancer Res. 71, 123–133 (2011).
44. R. T. Chlebowski et al., J. Natl. Cancer Inst. 98, 1767–1776 (2006).
45. J. P. Pierce et al., JAMA 298, 289–298 (2007).
46. T. M. Brasky et al., J. Natl. Cancer Inst. 105, 1132–1141 (2013).
47. T. M. Brasky et al., Am. J. Epidemiol. 173, 1429–1439 (2011).
48. M. Azrad et al., PLOS ONE 7, e53104 (2012).
49. E. Cohen et al., Nutrition 31, 727–732 (2015).
50. C. E. Forsythe et al., Lipids 43, 65–77 (2008).
51. D. S. Ludwig, JAMA 287, 2414–2423 (2002).
52. B. M. Hron, C. B. Ebbeling, H. A. Feldman, D. S. Ludwig, Nutr. Metab. 14, 44 (2017).
53. C. B. Ebbeling et al., JAMA 307, 2627–2634 (2012).
54. N. Mansoor, K. J. Vinknes, M. B. Veierød, K. Retterstøl, Br. J. Nutr. 115, 466–479 (2016).
55. J. S. Volek, M. L. Fernandez, R. D. Feinman, S. D. Phinney, Prog. Lipid Res. 47, 307–318 (2008).
56. J. S. Volek et al., Lipids 44, 297–309 (2009).
57. S. C. Cunnane et al., Front. Mol. Neurosci. 9, 53 (2016).
58. G. F. Cahill Jr., Annu. Rev. Nutr. 26, 1–22 (2006).
59. J. C. Newman, E. Verdin, Annu. Rev. Nutr. 37, 51–76 (2017).
60. K. F. Petersen et al., Proc. Natl. Acad. Sci. U.S.A. 104, 12587–12594 (2007).
61. J. Sackner-Bernstein, D. Kanter, S. Kaul, PLOS ONE 10, e0139817 (2015).
62. M. F. Hjorth, Y. Zohar, J. O. Hill, A. Astrup, Annu. Rev. Nutr. 38, 245–272 (2018).
63. D. S. Ludwig, C. B. Ebbeling, JAMA Intern. Med. 178, 1098–1103 (2018).
64. E. J. van Zuuren, Z. Fedorowicz, T. Kuijpers, H. Pijl, Am. J. Clin. Nutr. 108, 300–331 (2018).
65. L. Bozzetto et al., Diabetes Care 35, 1429–1435 (2012).
66. I. Shai et al., N. Engl. J. Med. 359, 229–241 (2008).
67. N. H. Bhanpuri et al., Cardiovasc. Diabetol. 17, 56 (2018).
68. P. W. Siri-Tarino, Q. Sun, F. B. Hu, R. M. Krauss, Am. J. Clin. Nutr. 91, 535–546 (2010).
69. M. Dehghan et al., Lancet 390, 2050–2062 (2017).
70. A. Poff, A. P. Koutnik, K. M. Egan, S. Sahebjam, D. D’Agostino, Semin. Cancer Biol. 10.1016/ j.semcancer.2017.12.011 (2017).
71. P. N. Hyde, M. B. Lustberg, V. J. Miller, R. A. LaFountain, J. S. Volek, Cancer Treat. Res. Commun. 12, 32–39 (2017).
72. B. D. Hopkins et al., Nature 560, 499–503 (2018).
73. A. Jans et al., Am. J. Clin. Nutr. 95, 825–836 (2012).
74. F. Rosqvist et al., Diabetes 63, 2356–2368 (2014).
75. A. E. Field, W. C. Willett, L. Lissner, G. A. Colditz, Obesity 15, 967–976 (2007).
76. F. B. Hu et al., N. Engl. J. Med. 345, 790–797 (2001).
77. H. Bjermo et al., Am. J. Clin. Nutr. 95, 1003–1012 (2012).
78. J. H. Y. Wu et al., Lancet Diabetes Endocrinol. 5, 965–974 (2017).
79. A. Keys, Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease (Harvard Univ. Press, 1980).
80. A. Keyes, J. T. Anderson, F. Grande, Metabolism 14, 747–758 (1965).
81. D. M. Hegsted, Am. J. Clin. Nutr. 44, 299–305 (1986).
82. R. P. Mensink, P. L. Zock, A. D. Kester, M. B. Katan, Am. J. Clin. Nutr. 77, 1146–1155 (2003).
83. F. M. Sacks et al., Circulation 136, e1–e23 (2017).
84. M. U. Jakobsen et al., Am. J. Clin. Nutr. 89, 1425–1432 (2009).
85. F. B. Hu et al., N. Engl. J. Med. 337, 1491–1499 (1997).
86. M. S. Farvid et al., Circulation 130, 1568–1578 (2014).
87. G. Zong et al., BMJ 355, i5796 (2016).
88. D. Mozaffarian, J. H. Wu, J. Am. Coll. Cardiol. 58, 2047–2067 (2011).
89. S. Petrova, P. Dimitrov, W. C. Willett, H. Campos, Public Health Nutr. 14, 1157–1164 (2011).
90. A. O’Connor, “Fish oil drug may reduce heart attack and stroke risks for some.” New York Times, 25 September 2018; www.nytimes.com/2018/09/25/well/fish-oil-heart-attackstroke-triglycerides-omega-3s.html.
91. B. S. Rett, J. Whelan, Nutr. Metab. 8, 36 (2011).
92. H. Su, R. Liu, M. Chang, J. Huang, X. Wang, Food Funct. 8, 3091–3103 (2017).
93. K. L. Fritsche, Prostaglandins Leukot. Essent. Fatty Acids 79, 173–175 (2008).
94. D. D. Wang et al., JAMA Intern. Med. 176, 1134–1145 (2016).
95. D. Mozaffarian, M. B. Katan, A. Ascherio, M. J. Stampfer, W. C. Willett, N. Engl. J. Med. 354, 1601–1613 (2006).
96. World Cancer Research Fund and American Institute for Cancer Research, Diet, Nutrition, Physical Activity and Cancer: A Global Perspective (2018); www.wcrf.org/sites/default/files/Summary-third-expert-report.pdf.
97. E. Cho et al., J. Natl. Cancer Inst. 95, 1079–1085 (2003).
98. E. Oken et al., Am. J. Epidemiol. 167, 1171–1181 (2008).
99. A. Horvath, B. Koletzko, H. Szajewska, Br. J. Nutr. 98, 253–259 (2007).
100. M. C. Morris, Proc. Nutr. Soc. 71, 1–13 (2012).
101. J. Palfreman, producer, “Diet Wars” episode of Frontline (WGBH-TV, 2004); www.pbs.org/wgbh/pages/frontline/shows/diet/.
102. C. D. Gardner et al., JAMA 319, 667–679 (2018).